Abiopharma

🔍 ROSENBLOOM KEITH M (Executive)

Company: AMERICAN VANGUARD CORP (AVD)

Report Date: 2026-06-04

Detailed Transactions and Holdings:

• Acquired 31,872 shares of Common Stock (Direct)
  Date: 2026-06-04 | Code: A | equity_swap_involved: false | shares_owned_after: 66,283.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These represent deferred stock units ("DSU") that were awarded as part of the Company's compensation program for non-management directors in connection with the 2026 annual stockholders' meeting. Each DSU constitutes the right to receive one share of the Company's common stock upon settlement (which occurs on the earlier to occur of either (i) when the recipient's service on the Company's board is concluded, (ii) a change of control or (iii) the recipient's death). During the remaining term of service, DSUs are nontransferable and carry neither voting nor dividend rights. DSUs are subject to the terms and conditions of the Company's standard form DSU agreement.